申请人:ABBVIE INC
公开号:WO2018188047A1
公开(公告)日:2018-10-18
Compounds of formula (I), wherein R 1, R 2, R 3, R 5, R 6, R 7, A 1, A 2, A 3, A 4, X 1, and X 2 have any of the values defined in the specification and pharmaceutically acceptable salts thereof, which are useful as agents in the treatment of diseases and conditions, including inflammatory diseases, cancer, and AIDS are provided. Pharmaceutical compositions comprising of compounds of formula (I) are also provided.
式(I)的化合物,其中R1、R2、R3、R5、R6、R7、A1、A2、A3、A4、X1和X2具有规范中定义的任何值及其药学上可接受的盐,这些化合物在治疗疾病和病况,包括炎症性疾病、癌症和艾滋病等方面是有用的。还提供了包含式(I)化合物的药物组合物。